Alirocumab is often preferred over evolocumab due to the ease of use with the SureClick autoinjector.

“I tend to use a I use whatever one I can get approved so it often is depends on the patient's Insurance mostly if all things you know being equal and either one being approved I probably tend to use more of a lock a map because you don't have to do the dose adjustment the sure click patent is really easy”